Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Bladder Cancer

  Free Subscription


01.05.2023

1 Actas Urol Esp (Engl Ed)
1 Adv Sci (Weinh)
1 Ann Med Surg (Lond)
1 Anticancer Res
1 Asian J Androl
1 Asian Pac J Cancer Prev
2 BJU Int
1 BMC Prim Care
1 BMC Urol
1 Cancer Control
1 Cancer Med
1 Cir Cir
1 Clin Genitourin Cancer
1 Environ Toxicol
1 ESMO Open
1 Eur J Cancer
1 Eur J Med Chem
1 Eur Radiol
1 Eur Urol Oncol
2 Eur Urol Open Sci
1 Expert Rev Anticancer Ther
1 Front Cell Infect Microbiol
1 Front Genet
1 Front Immunol
1 Front Public Health
2 Int J Mol Sci
1 J Cancer Res Clin Oncol
1 J Inflamm Res
1 J Transl Med
1 Medicine (Baltimore)
1 Molecules
1 Nan Fang Yi Ke Da Xue Xue Bao
2 Nat Commun
1 Nutr Cancer
1 Orv Hetil
1 Pharmaceuticals (Basel)
1 Pharmaceutics
1 Pharmacoeconomics
1 Plant Foods Hum Nutr
1 PLoS One
1 Prog Urol
1 Urol Pract
1 Urologie


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Actas Urol Esp (Engl Ed)

  1. ASTUDILLO C, Garcia-Perdomo HA
    Electronic cigarette: is it a risk factor for the development of bladder cancer?
    Actas Urol Esp (Engl Ed). 2023 Apr 20:S2173-5786(23)00047.
    PubMed        


    Adv Sci (Weinh)

  2. JING W, Chen C, Wang G, Han M, et al
    Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of Nanoporter-Encased Hydrogel Eradicates Bladder Carcinoma.
    Adv Sci (Weinh). 2023;10:e2206893.
    PubMed         Abstract available


    Ann Med Surg (Lond)

  3. AL-AZAB R, Al-Zubi M, Al Demour S, Khaled Al-Jamal S, et al
    Adherence to guidelines in the follow-up of non-muscle-invasive bladder cancer among urology trainers and trainees in Jordan: a cross-sectional study.
    Ann Med Surg (Lond). 2023;85:763-766.
    PubMed         Abstract available


    Anticancer Res

  4. SANO T, Aizawa R, Ito K, Nakamura K, et al
    Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma.
    Anticancer Res. 2023;43:2119-2126.
    PubMed         Abstract available


    Asian J Androl

  5. SUN MY, Peng Y, Liu DW, Wang K, et al
    Ectopic prostate tissue at the bladder trigone accompanied by cystitis glandularis and hemorrhage detected by multiparametric MRI.
    Asian J Androl. 2023;25:438-439.
    PubMed        


    Asian Pac J Cancer Prev

  6. GAUTAM KA, Raghav A, Sankhwar SN, Singh R, et al
    Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2023;24:1137-1141.
    PubMed         Abstract available


    BJU Int

  7. LAUKHTINA E, Moschini M, Krajewski W, Teoh JY, et al
    Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate.
    BJU Int. 2023;131:571-580.
    PubMed         Abstract available

  8. YANAGISAWA T, Miki J, Sato S, Takahashi H, et al
    Reply to Huseyin Besiroglu's Letter to the editor regarding the article 'Do we need repeat transurethral resection after en-bloc resection for pathological T1 bladder cancer?'.
    BJU Int. 2023 Apr 24. doi: 10.1111/bju.16035.
    PubMed        


    BMC Prim Care

  9. HOLTEDAHL K, Borgquist L, Donker GA, Buntinx F, et al
    Symptoms and signs of urogenital cancer in primary care.
    BMC Prim Care. 2023;24:107.
    PubMed         Abstract available


    BMC Urol

  10. GU S, Yang C
    Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients.
    BMC Urol. 2023;23:65.
    PubMed         Abstract available


    Cancer Control

  11. WU M, Zheng X, Wang X, Li X, et al
    The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study.
    Cancer Control. 2023;30:10732748231173475.
    PubMed         Abstract available


    Cancer Med

  12. HAGGSTROM C, Rowley M, Liedberg F, Coolen ACC, et al
    Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics and survival: A population-based nation-wide study in the Bladder Cancer Data Base Sweden (BladderBaSe).
    Cancer Med. 2023 Apr 25. doi: 10.1002/cam4.5981.
    PubMed         Abstract available


    Cir Cir

  13. YILDIZ AK, Ozgur BC, Bayraktar AS, Demir DO, et al
    How has the COVID-19 pandemic affected patients with primary bladder cancer?
    Cir Cir. 2023;91:204-211.
    PubMed         Abstract available


    Clin Genitourin Cancer

  14. HALSTUCH D, Lotan P, Karchever I, Rubinshtein D, et al
    Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer.
    Clin Genitourin Cancer. 2023 Mar 23:S1558-7673(23)00066.
    PubMed         Abstract available


    Environ Toxicol

  15. WU Q, Zhang H, You S, Xu Z, et al
    NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway.
    Environ Toxicol. 2023 Apr 23. doi: 10.1002/tox.23796.
    PubMed         Abstract available


    ESMO Open

  16. SHERMAN E, Lee JL, Debruyne PR, Keam B, et al
    Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study.
    ESMO Open. 2023;8:100877.
    PubMed         Abstract available


    Eur J Cancer

  17. CHUNG R, McKiernan J, Arpaia N, Marabelle A, et al
    Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity.
    Eur J Cancer. 2023;187:58-64.
    PubMed         Abstract available


    Eur J Med Chem

  18. LEONG SW, Wang J, Okuda KS, Su Q, et al
    Discovery of a novel dual functional phenylpyrazole-styryl hybrid that induces apoptotic and autophagic cell death in bladder cancer cells.
    Eur J Med Chem. 2023;254:115335.
    PubMed         Abstract available


    Eur Radiol

  19. PANEBIANCO V
    VI-RADS for the diagnosis and management of urinary bladder cancer.
    Eur Radiol. 2023 Apr 28. doi: 10.1007/s00330-023-09677.
    PubMed        


    Eur Urol Oncol

  20. LU YT, Plets M, Morrison G, Cunha AT, et al
    Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
    Eur Urol Oncol. 2023 Apr 20:S2588-9311(23)00074.
    PubMed         Abstract available


    Eur Urol Open Sci

  21. SORIA F, D'Andrea D, Barale M, Gust KM, et al
    Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guerin: Implications for Decision-making?
    Eur Urol Open Sci. 2023;50:17-23.
    PubMed         Abstract available

  22. FU Y, Liu K, Zhao L, Jiang X, et al
    Circular RNA Ubiquitin-associated Protein 2 Silencing Suppresses Bladder Cancer Progression by Downregulating DNA Topoisomerase 2-alpha Through Sponging miR-496.
    Eur Urol Open Sci. 2023;50:31-42.
    PubMed         Abstract available


    Expert Rev Anticancer Ther

  23. YASUI M, Cui L, Miyamoto H
    Recent advances in the understanding of urothelial tumorigenesis.
    Expert Rev Anticancer Ther. 2023;23:485-493.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  24. JAMES C, Gomez K, Desai S, Patel HD, et al
    Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer.
    Front Cell Infect Microbiol. 2023;13:1125809.
    PubMed         Abstract available


    Front Genet

  25. LIN Y, Li T, Li Z, Shen C, et al
    Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
    Front Genet. 2023;14:1097179.
    PubMed         Abstract available


    Front Immunol

  26. ZHAO Y, Li M, Wu W, Miao W, et al
    Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
    Front Immunol. 2023;14:1161273.
    PubMed         Abstract available


    Front Public Health

  27. MARSH GM, Kruchten A
    A reevaluation of selected mortality risks in the updated NCI/NIOSH acrylonitrile cohort study.
    Front Public Health. 2023;11:1122346.
    PubMed         Abstract available


    Int J Mol Sci

  28. HU B, Chen R, Jiang M, Xiong S, et al
    MTX-211 Inhibits GSH Synthesis through Keap1/NRF2/GCLM Axis and Exerts Antitumor Effects in Bladder Cancer.
    Int J Mol Sci. 2023;24:7608.
    PubMed         Abstract available

  29. ZHU J, Tong H, Sun Y, Li T, et al
    YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
    Int J Mol Sci. 2023;24:6905.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  30. GUO J, Liang X, Zheng Y, Ma J, et al
    Progress in the treatment of urethral adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:2693-2698.
    PubMed         Abstract available


    J Inflamm Res

  31. XU H, Lin T, Ai J, Zhang J, et al
    Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy.
    J Inflamm Res. 2023;16:1733-1744.
    PubMed         Abstract available


    J Transl Med

  32. LI J, Qi Y, Li B, Liu Y, et al
    STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer.
    J Transl Med. 2023;21:281.
    PubMed         Abstract available


    Medicine (Baltimore)

  33. PENG C, Guo S, Yang Z, Li X, et al
    A prognostic model for bladder cancer based on cytoskeleton-related genes.
    Medicine (Baltimore). 2023;102:e33538.
    PubMed         Abstract available


    Molecules

  34. WILCZAK M, Surman M, Przybylo M
    Altered Glycosylation in Progression and Management of Bladder Cancer.
    Molecules. 2023;28:3436.
    PubMed         Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  35. CAI T, Lu J, Lin Z, Lup M, et al
    [Intravesical instillation of bacillus Calmette-Guerin for non-muscle invasive bladder cancer: outcomes of 421 patients in a single center].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:488-494.
    PubMed         Abstract available


    Nat Commun

  36. WANG Y, Ju L, Wang G, Qian K, et al
    DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.
    Nat Commun. 2023;14:2421.
    PubMed         Abstract available

  37. ROBERTSON AG, Meghani K, Cooley LF, McLaughlin KA, et al
    Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
    Nat Commun. 2023;14:2126.
    PubMed         Abstract available


    Nutr Cancer

  38. ADAMS-MARDI C, Sparks A, Whalen M
    Impact of Minimally Invasive Approach to Radical Cystectomy in Bladder Cancer Patients with Malnutrition.
    Nutr Cancer. 2023 Apr 26:1-6. doi: 10.1080/01635581.2023.2202432.
    PubMed         Abstract available


    Orv Hetil

  39. MODOS O, Varadi M, Der B, Keszthelyi A, et al
    [Current diagnostic and treatment strategies for urachal cancer].
    Orv Hetil. 2023;164:602-609.
    PubMed         Abstract available


    Pharmaceuticals (Basel)

  40. ZHANG-YIN J, Girard A, Marchal E, Lebret T, et al
    PET Imaging in Bladder Cancer: An Update and Future Direction.
    Pharmaceuticals (Basel). 2023;16:606.
    PubMed         Abstract available


    Pharmaceutics

  41. KANG Y, Park C, Lee H, Kang S, et al
    Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery.
    Pharmaceutics. 2023;15:1117.
    PubMed         Abstract available


    Pharmacoeconomics

  42. JOYCE DD, Sharma V, Williams SB
    Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature.
    Pharmacoeconomics. 2023 Apr 23. doi: 10.1007/s40273-023-01273.
    PubMed         Abstract available


    Plant Foods Hum Nutr

  43. CHEN N, Li P, Liu L, Zhang J, et al
    Cucurbitacin IIb Extracted from Hemsleya penxianensis Induces Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells by Regulating Cell Cycle Checkpoints and Mitochondrial Apoptotic Pathway.
    Plant Foods Hum Nutr. 2023 Apr 22. doi: 10.1007/s11130-023-01058.
    PubMed         Abstract available


    PLoS One


  44. Expression of Concern: The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    PLoS One. 2023;18:e0284938.
    PubMed        


    Prog Urol

  45. SOOROJEBALLY Y, Neuzillet Y, Lebret T, Allory Y, et al
    Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
    Prog Urol. 2023 Apr 21:S1166-7087(23)00083-0. doi: 10.1016/j.purol.2023.
    PubMed         Abstract available


    Urol Pract

  46. MAGEE DE, Cheung DC, Hird AE, Chung P, et al
    Cost of Bladder Cancer Care: A Single Centre Comparison of Radical Cystectomy and Trimodal Therapy.
    Urol Pract. 2023 Apr 4:101097UPJ0000000000000403.
    PubMed         Abstract available


    Urologie

  47. ECKE TH, Wirtz RM, Friedersdorff F, Fussel S, et al
    [Research in bladder cancer: translation into the clinic-report of 13th annual meeting of the German Research Group on Bladder Cancer (DFBK) in Berlin].
    Urologie. 2023 Apr 28. doi: 10.1007/s00120-023-02093.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: